• Research Topics

  Fight MND Phase 2 study

  Posted by Amanda on April 25, 2019 at 6:18 pm

  https://alsnewstoday.com/2019/04/24/fightmnd-grant-to-fund-phase-2-study-of-investigational-therapy-for-als/

  An Australia-based organization called FightMND has granted about $700,000 to biopharmaceutical company to  fund  a randomized, double-blind, placebo-controlled  study on the CuATSM drug.   To learn more about the second phase of the study and for the link for information on the clinical trial read the attached article.

  What do you think about this study? 

  replied 5 years ago 1 Member · 0 Replies

  • ALS
  • ALS medication
  • ALS treatment
  • ALS trial studies
  • fALS
  • Fight ALS
  • pALS
• 0 Replies

Log In to Reply